BACLOFEN A 2MG/ML INJECTION 20 ML
BACLOFEN A 2MG/ML INJECTION 20 ML – Advanced Treatment for Severe Spasticity
As referenced on Nahdi Online, Baclofen A 2mg/ml Injection is a specialized medication designed for the effective management of severe, chronic spasticity. This condition, often resulting from multiple sclerosis, spinal cord injury, or other neurological disorders, can cause painful muscle spasms and significantly impair mobility. Baclofen, as an active ingredient, works by acting on the central nervous system to reduce the frequency and severity of these involuntary muscle contractions, helping to restore a degree of motor function.
On platforms like and , while not always readily available for prescription injectables, the importance of such medications for chronic conditions is often highlighted through related medical supplies and information. Baclofen Injection is particularly indicated for patients whose spasticity is unresponsive to oral baclofen or other conventional antispastic agents, providing a crucial alternative for better symptom control and improved quality of life.
Benefits of Use
- Significantly reduces the severity and frequency of painful muscle spasms.
- Improves muscle tone and reduces stiffness, facilitating better movement and rehabilitation efforts.
- Offers an effective solution for severe chronic spasticity unresponsive to oral treatments.
- Can enhance daily living activities and overall quality of life for patients.
How to Use
- Baclofen A 2mg/ml Injection is for intrathecal administration only and must be administered by a qualified healthcare professional.
- The initial dosage is carefully determined and titrated based on the individual patient's response and the severity of their spasticity.
- Administration typically involves a test dose, followed by gradual increases to achieve optimal therapeutic effect.
- Regular monitoring by medical personnel is essential throughout the treatment course to adjust dosage and manage potential side effects.
Caution & Warnings
Strictly for intrathecal administration; do not administer intravenously, intramuscularly, or subcutaneously.
Abrupt discontinuation of intrathecal baclofen can lead to a severe withdrawal syndrome, including high fever, altered mental status, exaggerated spasticity, and muscle rigidity, potentially leading to seizures, rhabdomyolysis, organ failure, and death. Consult your physician before stopping.
Patients must be closely monitored for signs of overdose, which may include drowsiness, lightheadedness, excessive hypotonia, and respiratory depression.
May cause central nervous system depression; advise patients to avoid activities requiring mental alertness, such as driving or operating machinery, until they know how the medication affects them.
Exercise caution in patients with a history of epilepsy, psychiatric disorders, or renal impairment.
Not recommended for use in pregnant or breastfeeding women unless clearly necessary and the potential benefits outweigh the risks.
Ingredients
Active Ingredient: Baclofen 2mg/ml
Excipients: Sodium Chloride, Water for Injection (specific excipients may vary by manufacturer).
Product Details
Form: Solution for Injection
Strength: 2mg/ml
Volume: 20 ML per vial
Route of Administration: Intrathecal
Legal Status: Prescription Only Medicine
| Gtin | 4-5299-19 |
|---|---|
| Recommended Sale Price | 1099.55 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | BACLOFEN |
| SFDA Reg. No | 4-5299-19 |
| IBC | 4-5299-19 |
| Drug Type | Prescription |
| Scientific Name | Baclofen |
| Strength | 2MG/ML |
| Strength Unit | MG/ML |
| Form | Injection |
| Admin Route | Intrathecal |
| Size | 20 ML |
| Size Unit | ML |
| Package Types | Vial |
| Package Size | 20 ML |
| Storage conditions | Store at controlled room temperature, protect from freezing. |
| Refrigerator Storage | No |
